Using ultrasound to assess the impact of vaping in adolescents
Point-of-Care Ultrasound Findings and Impact on Vaping Behaviors in Adolescents
This study is testing how vaping affects the lungs of teens aged 12-18 by using ultrasound to see if there are any changes in their lung health.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 200 (estimated) |
| Ages | 12 Years to 18 Years |
| Sex | All |
| Sponsor | Medical University of South Carolina Academic / other |
| Locations | 1 site (Charleston, South Carolina) |
| Trial ID | NCT06335329 on ClinicalTrials.gov |
What this trial studies
This study investigates the effects of vaping among adolescents by utilizing point-of-care ultrasound (POCUS) to identify lung findings associated with vaping. It aims to enroll participants aged 12-18 who have a history of vaping or are non-vapers, and will involve discussions about ultrasound findings. The study seeks to enhance understanding of the health implications of vaping in young individuals and promote awareness of its risks. Participants will be monitored for their lung health through ultrasound imaging, which may provide valuable insights into the consequences of vaping.
Who should consider this trial
Good fit: Ideal candidates for this study are adolescents aged 12-18 who have access to a cell phone or email and belong to a vaping history group.
Not a fit: Patients with chronic lung diseases or significant acute medical conditions may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved awareness and understanding of the health risks associated with vaping among adolescents.
How similar studies have performed: While there is ongoing research into vaping and its health effects, the use of point-of-care ultrasound specifically for this purpose is relatively novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Ages 12-18 years of age * Has own individual cell phone or email for communication * Member of a vaping history group that is not yet full for enrollment (ex: up to 100 vapers, up to 100 non-vapers) * Able to speak and understand English Exclusion Criteria: * Chronic Lung Disease * History of pneumothorax * Prior thoracic surgery including VATS (Video-assisted thoracoscopic surgery) * Sickle cell disease * Current or prior cancer * Significant congenital heart disease * Acute upper respiratory infection (cough or congestion in the last 3 days) * Acute chest trauma * Acute pulmonary embolism * Sedation medication administered prior to study image acquisition * Known allergy or sensitivity to ultrasound gel * Significant acute psychosis, mania, or suicidal ideation * Any other medical or psychiatric condition or other significant concern that in the investigator's opinion would impact participant safety or compliance with study instructions, or potentially confound the interpretation of findings * Inability or unwillingness of subject or legal guardian/representative to give informed consent/assent.
Where this trial is running
Charleston, South Carolina
- Medical University of South Carolina — Charleston, South Carolina, United States (Recruiting)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.